These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23297287)

  • 1. 'Clock' times to assess medical devices.
    Moscovitch B
    Health Aff (Millwood); 2013 Jan; 32(1):192. PubMed ID: 23297287
    [No Abstract]   [Full Text] [Related]  

  • 2. New medical devices: the author's reply to Brock.
    Zinn AM; Allen JC; Hacker CS
    Health Aff (Millwood); 2013 Jan; 32(1):192-3. PubMed ID: 23297288
    [No Abstract]   [Full Text] [Related]  

  • 3. CMS national coverage determinations for devices.
    Brock JA; Jensen TS; Jacques LB
    Health Aff (Millwood); 2013 Jan; 32(1):192. PubMed ID: 23297286
    [No Abstract]   [Full Text] [Related]  

  • 4. Median approval times for class III medical devices have been well above statutory deadlines set for FDA and CMS.
    Zinn AM; Allen JC; Hacker CS
    Health Aff (Millwood); 2012 Oct; 31(10):2304-13. PubMed ID: 23048112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals and Medical Devices: FDA Oversight.
    Berry MD; White RS;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-59. PubMed ID: 28252888
    [No Abstract]   [Full Text] [Related]  

  • 6. More safety data sought for high-risk devices.
    Voelker R
    JAMA; 2009 May; 301(18):1867. PubMed ID: 19436007
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown?
    Rathi VK; Johnston JL; Ross JS; Dhruva SS
    N Engl J Med; 2021 Mar; 384(12):e43. PubMed ID: 33691059
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the security and privacy of implantable medical devices.
    Maisel WH; Kohno T
    N Engl J Med; 2010 Apr; 362(13):1164-6. PubMed ID: 20357279
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and Medical Devices: FDA Oversight.
    White RS;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-33. PubMed ID: 29361662
    [No Abstract]   [Full Text] [Related]  

  • 10. The blind hog and the acorn: Medicare coverage for investigational devices.
    Betz R
    J Healthc Resour Manag; 1995 Mar; 13(3):31-2. PubMed ID: 10154864
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adopting medical technology.
    Berliner E
    Med Decis Making; 2014 Nov; 34(8):948-50. PubMed ID: 25224365
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18236-7. PubMed ID: 11010624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Express preemption and premarket approval under the Medical Device Amendments.
    Scandaglia GJ; Tully TL
    Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395
    [No Abstract]   [Full Text] [Related]  

  • 18. Modernizing device regulation.
    Kretzer RM; Foreman CL; Shuren J
    N Engl J Med; 2010 Jul; 363(2):196-7; author reply 197. PubMed ID: 20653080
    [No Abstract]   [Full Text] [Related]  

  • 19. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
    Mottes LM
    Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761
    [No Abstract]   [Full Text] [Related]  

  • 20. Miracles in the making.
    Wagner L
    Provider; 2003 Mar; 29(3):22-6, 28, 31-6. PubMed ID: 12666330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.